Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chahrazade Kantari-Mimoun

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal for Immunotherapy of Cancer|May 8, 2026
Phase 1 multicenter study of the NKG2A targeting antibody S095029 as a single agent and in combination with anti-PD-1 in patients with advanced malignanciesAung Naing, Anna Spreafico, Minal Barve, et al.
The EMBO Journal|March 5, 2017
The linear ubiquitin chain assembly complex regulates TRAIL-induced gene activation and cell deathElodie Lafont, Chahrazade Kantari-Mimoun, Peter Draber, et al.
Nature Communications|August 20, 2016
Targeting VEGF-A in myeloid cells enhances natural killer cell responses to chemotherapy and ameliorates cachexiaRalph Klose, Ewelina Krzywinska, Magali Castells, et al.
Frontiers in Immunology|November 1, 2024
<i>In silico</i> and pharmacological evaluation of GPR65 as a cancer immunotherapy target regulating T-cell functionsShamin Li, Fabien Melchiore, Chahrazade Kantari-Mimoun, et al.
Hepatology (Baltimore, Md.)|December 6, 2014
Resolution of liver fibrosis requires myeloid cell-driven sinusoidal angiogenesisChahrazade Kantari-Mimoun, Magali Castells, Ralph Klose, et al.
Oncotarget|January 25, 2017
Boosting the hypoxic response in myeloid cells accelerates resolution of fibrosis and regeneration of the liver in miceChahrazade Kantari-Mimoun, Ewelina Krzywinska, Magali Castells, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 11, 2018
Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti-PD-1 treatmentElisa Peranzoni, Jean Lemoine, Lene Vimeux, et al.
The Journal of Biological Chemistry|March 11, 2016
Proteinase 3 Is a Phosphatidylserine-binding Protein That Affects the Production and Function of MicrovesiclesKatherine R Martin, Chahrazade Kantari-Mimoun, Min Yin, et al.
Elife|June 9, 2021
Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatmentAlba Nicolas-Boluda, Javier Vaquero, Lene Vimeux, et al.
Nature Communications|November 19, 2017
Loss of HIF-1α in natural killer cells inhibits tumour growth by stimulating non-productive angiogenesisEwelina Krzywinska, Chahrazade Kantari-Mimoun, Yann Kerdiles, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal for Immunotherapy of Cancer|May 8, 2026
Phase 1 multicenter study of the NKG2A targeting antibody S095029 as a single agent and in combination with anti-PD-1 in patients with advanced malignanciesAung Naing, Anna Spreafico, Minal Barve, et al.
The EMBO Journal|March 5, 2017
The linear ubiquitin chain assembly complex regulates TRAIL-induced gene activation and cell deathElodie Lafont, Chahrazade Kantari-Mimoun, Peter Draber, et al.
Nature Communications|August 20, 2016
Targeting VEGF-A in myeloid cells enhances natural killer cell responses to chemotherapy and ameliorates cachexiaRalph Klose, Ewelina Krzywinska, Magali Castells, et al.
Frontiers in Immunology|November 1, 2024
<i>In silico</i> and pharmacological evaluation of GPR65 as a cancer immunotherapy target regulating T-cell functionsShamin Li, Fabien Melchiore, Chahrazade Kantari-Mimoun, et al.
Hepatology (Baltimore, Md.)|December 6, 2014
Resolution of liver fibrosis requires myeloid cell-driven sinusoidal angiogenesisChahrazade Kantari-Mimoun, Magali Castells, Ralph Klose, et al.
Oncotarget|January 25, 2017
Boosting the hypoxic response in myeloid cells accelerates resolution of fibrosis and regeneration of the liver in miceChahrazade Kantari-Mimoun, Ewelina Krzywinska, Magali Castells, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 11, 2018
Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti-PD-1 treatmentElisa Peranzoni, Jean Lemoine, Lene Vimeux, et al.
The Journal of Biological Chemistry|March 11, 2016
Proteinase 3 Is a Phosphatidylserine-binding Protein That Affects the Production and Function of MicrovesiclesKatherine R Martin, Chahrazade Kantari-Mimoun, Min Yin, et al.
Elife|June 9, 2021
Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatmentAlba Nicolas-Boluda, Javier Vaquero, Lene Vimeux, et al.
Nature Communications|November 19, 2017
Loss of HIF-1α in natural killer cells inhibits tumour growth by stimulating non-productive angiogenesisEwelina Krzywinska, Chahrazade Kantari-Mimoun, Yann Kerdiles, et al.
Pageof 2